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Introduction: COPD is a leading cause of morbidity and mortality. Self-management 
interventions are considered important in order to limit the progression of the disease. Computer-
tailored interventions could be an effective tool to facilitate self-management.
Methods: This randomized controlled trial tested the effectiveness of a web-based, computer-
tailored COPD self-management intervention on physical activity and smoking behavior. 
Participants were recruited from an online panel and through primary care practices. Those at risk 
for or diagnosed with COPD, between 40 and 70 years of age, proficient in Dutch, with access 
to the Internet, and with basic computer skills (n=1,325), were randomly assigned to either the 
intervention group (n=662) or control group (n=663). The intervention group received the web-
based self-management application, while the control group received no intervention. Participants 
were not blinded to group assignment. After 6 months, the effect of the intervention was assessed 
for the primary outcomes, smoking cessation and physical activity, by self-reported 7-day point 
prevalence abstinence and the International Physical Activity Questionnaire – Short Form.
Results: Of the 1,325 participants, 1,071 (80.8%) completed the 6-month follow-up question-
naire. No significant treatment effect was found on either outcome. The application however, 
was used by only 36% of the participants in the experimental group.
Conclusion: A possible explanation for the nonsignificant effect on the primary outcomes, 
smoking cessation and physical activity, could be the low exposure to the application as engage-
ment with the program has been shown to be crucial for the effectiveness of computer-tailored 
interventions. (Netherlands Trial Registry number: NTR3421.)
Keywords: smoking cessation, physical activity, Internet intervention, tailoring, COPD
Background
COPD is one of the leading causes of morbidity and mortality worldwide.1 COPD 
patients suffer from airflow limitation that is typically progressive and not reversible.2 
Adequate patient self-management and behavior modification, such as smoking ces-
sation and increasing the level of physical activity, are recommended to decelerate 
disease progression.3,4
A relatively small number of studies on the effectiveness of COPD self-management 
interventions have been conducted, and the evidence on effectiveness remains 
inconclusive.5 Self-management interventions have mainly focused on educating COPD 
patients using standardized information, but are now increasingly offering personalized 
information to patients through counseling with a health care provider.5
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Another trend in providing health-promoting information 
is e-Health, which uses information and communication 
technology.6 Information provided by e-Health interventions 
has been individualized using computer-tailored technology, 
often with disease prevention as a main goal.7–9 This interven-
tion method offers computer-generated, personally relevant 
information by adapting the content of health-promotion mes-
sages to users’ characteristics.9 Personalizing and adapting 
health messages has been found to help attract and keep users’ 
attention, increase appreciation, and help users process mes-
sages more thoroughly.10–12 Computer-tailored interventions 
have been shown to effectively improve health behaviors, 
such as smoking cessation and physical activity.13,14 This 
intervention strategy has also been successful when targeting 
multiple behaviors11 and has been found to be more cost-
effective than usual care.15 To our knowledge, this promising 
technique has not yet been tested with the purpose of sup-
porting behavior change in COPD patients.
In the MasterYourBreath (“AdemDeBaas” in Dutch) 
project, we developed a web-based, computer-tailored self-
management application for COPD patients. We evaluated 
and improved the usability of the prototype16 and conducted 
a pilot study.17 In the present paper, we report the effective-
ness of this intervention on behavioral (physical activity, 
smoking cessation, and the intention to be more physically 
active and to quit smoking) and clinical outcomes (clinical 
disease control and dyspnea).
Methods
study design
This randomized controlled trial (RCT) compared an inter-
vention group which received a COPD self-management 
application to a control group that did not receive the inter-
vention. All participants, whether they were assigned to the 
control or intervention group, were free to receive usual care 
or use other resources in order to help them manage their 
disease or improve their lifestyle.
In the Netherlands, a COPD disease-management 
approach is widely implemented.18 This approach includes 
a practice nurse who coaches patients to improve their self-
management behavior. We originally planned to integrate 
the intervention in this disease-management approach, but 
our pilot study had shown that it was not feasible to recruit 
enough patients to cover the sample size required for our 
RCT if the practice nurse recruited the patients.17 Instead, 
to solve the recruitment issues, we invited patients from 
five general practices by mail and recruited patients from a 
Dutch online panel. We also broadened our inclusion criteria 
to include people at risk for COPD as well as people with 
known COPD.
The Dutch online panel was assembled by the company 
Flycatcher Internet Research BV (www.flycatcher.eu) which 
is an institute for online research certified by the International 
Organization for Standardization. In total, the online panel 
consisted of 16,000 Dutch-speaking members, who had an 
email address and were at least 12 years old. All age groups, 
education levels, and provinces of the Netherlands were 
represented in the panel. Flycatcher’s members are recruited 
by Flycatcher through newsletters, send-to-a-friend promo-
tions, third parties’ contact lists used for research (with the 
permission of the owner of the contact list and the person on 
the list), and word-of-mouth advertising. Members receive 
seven research questionnaires a year on average.
Members from the Dutch online panel and the five general 
practices were eligible for participation in this study if they 
were diagnosed with COPD or were at moderate or high risk 
for COPD, were between 40–70 years of age, were proficient 
in Dutch, and had access to the Internet and basic computer 
skills. Dutch proficiency and basic computer literacy were 
gauged by administration of the first online questionnaire. 
The Respiratory Health Screening Questionnaire (RHSQ)19 
was used to assess the subject’s risk for COPD. This question-
naire contains ten items related to important determinants of 
COPD for individuals of 40 years and older.19 A scoring sys-
tem for case-finding20,21 was used to determine if an individual 
was at low (16.5 points), moderate (16.5–19.5 points), or 
high risk (19.5 points) for COPD (sensitivity =58.7%, 
specificity =77.0%, for the 16.5 cutoff point).20
The five general practices were involved in a parallel 
project21 in which 40- to 70-year-old patients had already 
been screened for COPD by their general practitioner using 
the RHSQ. Potentially eligible members of the online panel 
were invited for the study by an email from Flycatcher, 
including a study information letter. Members who decided 
to participate were screened for eligibility by completing 
the RHSQ. We implemented a scoring algorithm within 
the online questionnaire, so eligibility could be determined 
directly after participants completed the questionnaire. Mem-
bers received a small incentive equal to €2.55 per completed 
questionnaire (baseline and follow-up). Figure 1 shows the 
Consolidated Standards of Reporting Trials (CONSORT) 
diagram including the two populations.
The study was approved by the Medical Ethical Com-
mittee of Maastricht University Medical Center (METC 
12-4-033) and registered with the Netherlands Trial Reg-
istry (NTR3421). All participants received an online study 
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information letter and completed an online informed consent 
form before entering the study. A more detailed description 
of the methods can be found in a study protocol published 
elsewhere.22
randomization
A permuted block design23 with a random block size vary-
ing from four to 20 was employed to randomize participants 
stratified by channel of recruitment (online or through general 
practice). This approach was chosen in order to achieve bal-
anced and evenly distributed samples for both recruitment 
strategies. A researcher not involved in data collection or 
analysis of the results performed the randomization using 
PROC PLAN in SAS software (v 9.1; SAS Institute, Cary, 
NC, USA). Due to the study design, it was not feasible to 
blind participants to group assignments.
Intervention
MasterYourBreath application
The intervention, “MasterYourBreath”,22 was designed to 
change participants’ health behavior by means of a web-
based application providing computer-generated tailored 
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Figure 1 Consolidated standards of reporting Trials diagram.
Abbreviation: gP, general practice.
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feedback. The intervention was based on earlier studies 
on computer-tailored feedback for lifestyle changes which 
have been shown to be effective and cost-effective11,24–26 and 
adapted to our target groups. The MasterYourBreath appli-
cation was built using the online application Tailorbuilder 
(OverNite Software Europe, Sittard, Netherlands).
Participants assigned to the experimental group were 
asked by email to access the application with a personalized 
account and use the application ad libitum for 6 months. 
Participants in the online group received the email from 
Flycatcher and those in the general practice group from the 
research team. Application use was monitored by the research 
team and email prompts were sent to encourage application 
use,27 mostly within a 2-week time interval addressing new 
content on the website, as this could increase the number of 
follow-up visits.28 The application had a modular design, 
including two behavior-change modules, smoking cessation 
and physical activity. Each module was equally divided into 
six intervention components: (1) health-risk appraisal: feed-
back on the behavior (smoking or physical activity) based 
on Dutch guidelines; (2) motivational beliefs: feedback on 
perceived positive and negative consequences of the behav-
ior; (3) social influence: feedback on the social influences 
of participants’ partner, family, friends, and coworkers on 
the behavior; (4) goal setting and action plans: feedback on 
achievement of goals and on action plans in order to achieve 
their goal; (5) self-efficacy: feedback on perceived barriers to 
change the behavior; and (6) maintenance: feedback in order 
to maintain the healthy behavior. Participants could switch 
behavior-change modules and choose to enter one or more 
intervention components according to their preference.10
Feedback was personalized using participants’ names 
and tailored to participants’ characteristics and key behav-
ior determinants of psychosocial constructs, for which the 
I-Change model served as theoretical framework.29,30 Exam-
ples of the key behavior determinants are: pros and cons of 
physical activity, perceived social support to quit smoking, 
action plans to increase physical activity, and self-efficacy to 
cope with barriers to quit smoking. Participants were asked 
questions to uncover their personal determinants, using 
questionnaires that have been tested experimentally among 
Dutch adults in previous studies in the general public.13,31,32 
These questionnaires were adjusted for COPD patients dur-
ing the usability study.16 The questions were used to generate 
tailored feedback to the participants about their responses. 
Participants’ previous responses were also incorporated in 
the feedback so they could track their own behavior change 
and goal attainment over the course of the study. The six 
intervention components per module were available to 
the participants to be completed over time as they chose. 
This allowed participants the ability to track their behavior 
changes by comparing the most current answers with the 
previous answers.
A more detailed description of the intervention and 
prompt protocol is described elsewhere.22
Website
The computer-tailored application was embedded in a web-
site. The website contained general information about the 
MasterYourBreath project, COPD/being at risk for COPD, 
smoking, and physical activity. Online self-management 
resources, such as videos with home exercises (seven exer-
cises focusing on strength and balance) and hyperlinks to 
other informative websites, were also included. The tailored 
feedback and prompts referred participants to the home 
exercises and other resources.
Data collection
A web-based questionnaire was administered at baseline 
between May and November of 2012 with a follow-up ques-
tionnaire sent out 6 months later. The frequency of remind-
ers for completing these questionnaires was adapted to the 
response rate. The online group received one reminder to par-
ticipate in the study and complete the baseline questionnaire. 
General practice group participants received two additional 
reminders if they responded to the invitation but did not 
complete the baseline questionnaire, since the participation 
rate in this group was low. The online group received one 
reminder to complete the follow-up questionnaire, whereas 
the general practice group received two reminders. Data col-
lection ended in July 2013. All data were captured through 
these questionnaires, except demographic characteristics in 
the online group, as these were already documented through 
an annual update process undertaken by Flycatcher.
Outcome measures
Two primary outcomes were measured, one for each health 
behavior: smoking cessation and physical activity. Smoking 
cessation was assessed by one item measuring the 7-day 
point prevalence abstinence,33,34 and the level of physical 
activity was assessed by the International Physical Activity 
Questionnaire – Short Form.35
We created a “behavior-change score” by combining the 
two behaviors (smoking cessation and physical activity). 
The behavior-change score was only calculated for partici-
pants who smoked at baseline or were below the physical 
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activity norm (defined as being physically active for at least 
30 minutes a day on 5 days a week at a moderate or vigorous 
intensity). The efforts of participants were rated as “success-
ful behavior change” if they achieved smoke-free status for 
7 consecutive days prior to the follow-up measurement, or if 
they achieved the norm level of physical activity at follow-up, 
reflecting a change from their baseline behavior. The actions 
of participants who smoked or were below the physical activ-
ity norm at baseline and achieved neither smoke-free status 
nor the norm level of physical activity at follow-up were 
rated as “unsuccessful behavior change”.
Secondary outcomes included secondary smoking cessa-
tion measures, health status, and intention to change behav-
ior. Secondary smoking cessation measures were: number 
of quit attempts during the past 6 months, 24-hour point 
prevalence abstinence, tobacco consumption, and continued 
and prolonged abstinence.33,34 To assess participants’ health 
status, participants were asked if they experienced any form 
of breathlessness, and if so, the Medical Research Council 
(MRC) dyspnea scale was administered in order to measure 
the level of disability.36 Clinical disease control was measured 
using the Clinical COPD Questionnaire. This questionnaire 
assesses both patient guideline goals (health-related quality of 
life) and clinical guideline goals such as prevention of disease 
progression.37 Intention to change behavior was measured by 
separate questions for physical activity and smoking. Table 1 
presents an overview of all outcomes including how and 
when they were measured.
Baseline measurements
There were several additional baseline measures that were 
not part of the primary and secondary outcome measures, 
including demographic characteristics: age, sex, marital sta-
tus, education level, and current employment status. Several 
additional questions were asked at baseline to capture smoking 
behavior. Participants were asked if they had ever smoked 
and about their number of previous quit attempts. The six-
item version of the Fagerström Test for Nicotine Dependence 
(0= not addicted; 10= highly addicted)38 was included in order 
to assess the addiction level. Health status was further esti-
mated, measuring COPD status and comorbidities, by asking 
participants whether they were diagnosed with COPD or any 
other chronic disease, and which other chronic disease(s).
sample-size calculation
Sample-size calculations assumed 80% power and a signifi-
cance level of 0.05 for both behaviors and were completed by 
PS software version 3.0.43,39 according to Fisher’s exact test. 
Calculations for smoking indicated that 446 participants per 
group were necessary at the end of the trial to detect a 10% 
difference in 7-day point prevalence (20% abstinence in the 
intervention group, compared to 10% in the control group31). 
We based this calculation on the assumption that 49.2% of 
the population with an increased risk for COPD smoked at 
baseline.40 The number needed for measuring physical activ-
ity was smaller and could be obtained following the above 
sample-size calculation for smoking.22 In another study 
the standard deviation was 26.63 minutes a day in a Dutch 
population.41 When including 446 participants per group, a 
difference of 5 minutes a day, which corresponds to a small 
standardized effect size (Cohen’s d =0.2), could be detected. 
In order to allow for a 30% drop-out rate, a baseline total of 
1,275 participants was necessary to reach 80% power.
analyses
Differences at baseline between groups (intervention vs 
control; and participants who dropped out vs who did not 
drop out) were compared using chi-square tests for categori-
cal variables and independent-samples t-tests for numerical 
variables. Data were analyzed according to the intention-to-
treat principle. For both primary outcomes, an additional per 
protocol analysis was conducted. Participants assigned to the 
experimental group had to have completed at least one of the 
six intervention components of the specific behavior module 
to be included in the latter analysis. For the “per protocol” 
analyses, we conducted two sensitivity analyses with stricter 
criteria for each primary outcome (smoking cessation and 
physical activity). For the first analyses, we included only 
participants who completed at least two intervention com-
ponents of the specific behavior module. For the second 
analyses, we included only participants who completed at 
least three intervention components, since a higher “usage 
dose” may be necessary to yield a treatment effect.
The uncorrected and corrected effects of the intervention 
on the primary and secondary outcomes were assessed using 
logistic regression for categorical outcomes and linear regres-
sion for numerical outcomes measured at 6 months. Linear 
mixed models were used for outcomes measured at baseline 
and at 6 months to account for the correlation between 
repeated measurements of the same participant and to include 
all participants, including those with missing data. As for 
correction, the models included: the stratification variable – 
that is, recruitment channel (online or general practices); 
baseline variables if they showed a statistically significant 
difference between intervention and control group; and 
baseline variables that were related to drop out, missing data, 
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Table 1 Primary and secondary outcomes
Outcome(s) Measurement Scale Time
Primary
smoking cessation: 7-day 
point prevalence abstinence
1 item assessing whether participant smoked 
during the last 7 daysa
0= did not refrain from smoking 
during the last 7 days; 1= refrained 
from smoking during the last 7 days
Follow-up
level of physical activity IPaQ-sFb MeT minutes a week (last 7 days): 
vigorous physical activity =8.0 MeTs; 
moderate physical activity =4.0 
MeTs; walking =3.3 MeTs
Baseline and 
follow-up
Secondary
Quit attempts 1 item assessing the number of quit attempts 
during the past 6 monthsa
number of quit attempts during the 
past 6 months
Follow-up
24-hour point prevalence 
abstinence 
1 item assessing whether participant smoked 
during the last 24 hoursa
0= did not refrain from smoking 
during the last 24 hours; 1= refrained 
from smoking during the last 
24 hours
Follow-up
Continued abstinence 1 item assessing when the last serious quit 
date was, and 1 item assessing smoking 
behavior since that datea
0= smoked since the last quit date; 
1= did not smoke at all since the last 
quit date
Follow-up
Prolonged abstinence 1 item assessing when the last serious quit 
date was, and 1 item assessing smoking 
behavior since that date, allowing a grace 
period of 2 weeks in which smoking 
behavior was not counted as sucha
0= smoked since 2 weeks after the 
last quit date; 1= did not smoke at all 
since 2 weeks after the last quit date
Follow-up
Tobacco consumption 4 items assessing what products (cigarettes, 
rolling tobacco, cigars, or pipe tobacco) are 
currently smoked, and 4 items assessing how 
much of each product is currently smokeda 
number of cigarettesf Baseline and 
follow-up
Dyspnea status 1 item, MrC scalec 1–5; higher score means worse 
dyspnea
Baseline and 
follow-up
Clinical disease control 10-item CCQd 0= very good control; 6= extremely 
poor control
Baseline and 
follow-up
Intention to quit smoking 1 item, 7-point likert scalee 1= I certainly plan to quit smoking; 
7= I certainly do not plan to quit 
smoking
Baseline and 
follow-up
Intention to increase the 
level of physical activity
1 item, 7-point likert scalee 1= I certainly plan to be more 
physically active; 7= I certainly do 
not plan to be more physically active
Baseline and 
follow-up
Notes: asmoking cessation questions were selected based on the russel standard33 and a Dutch guide published by stivoro that aimed to standardize smoking cessation 
measures in the netherlands.34 Self-report has been shown to be reliable in COPD patients: kappa coefficient =0.20 for biochemical validation at 6-month measurement, 
P=0.003.61 bThe reliability and validity of the IPaQ-sF have been tested in the Dutch population: test–retest reliability, ρ=0.85; concurrent validity between long and short 
IPaQ, from ρ=0.85 to 0.88; criterion validity against accelerometer, ρ=0.32.35 cThe MRC scale is a useful measure for disability. Significant associations were found between 
disability MrC grade and shuttle distance, st george respiratory Questionnaire,62 Chronic respiratory Questionnaire63 scores, mood state, and nottingham extended 
activities of Daily living64 scores. Forced expiratory volume in one second was not associated with MrC grade.36 dThe CCQ is validated in the Dutch population and 
can be used for COPD patients and individuals at risk for COPD: Cronbach’s alpha =0.91(internal consistency), significantly higher score of people with or at risk for 
COPD compared to healthy (ex-)smokers (P0.05) (discriminate validity), significant correlations with 36-Item Short Form Health Survey (ρ=0.48–0.69)65 and st george 
respiratory Questionnaire (ρ=0.67–0.72) (internal consistency); correlation with forced expiratory volume in one second % predicted ρ=–0.49 (divergent validity); intra class 
coefficient =0.94 (test–retest reliability); significant improvement in CCQ found after 2 months’ smoking cessation (responsiveness).37 eThe intention questions were based 
on the I-Change model.29,30 The “intention to quit smoking” question has previously been used successfully in a similar intervention study.66 fThe overall score for tobacco 
consumption was expressed as the number of cigarettes, whereby one hand-rolled cigarette equaled one commercial cigarette, and one cigar equaled four cigarettes.34 
We considered one pipe to equal one cigarette, since no concrete guidelines were available on converting the number of pipes to cigarettes.
Abbreviations: CCQ, Clinical COPD Questionnaire; IPaQ-sF, International Physical activity Questionnaire – short Form; MeT, metabolic equivalent task; MrC, Medical 
research Council.
and/or related to the outcome at 6 months (P value 0.20 in 
univariable regression analysis) to increase the precision of 
the intervention effect. To assess potential effect modifiers, 
the interaction of the treatment variable with age, sex, inten-
tion to increase level of physical activity, educational level, 
dyspnea status, and COPD status were added in the corrected 
mixed-model analyses for level of physical activity. Primary 
outcomes were analyzed for subgroups based on age (40–50, 
50–60, 60–70), sex, intention to change behavior (those who 
had no intention or were not sure; those who intended to 
change), education level (low, middle, high), dyspnea (yes, 
no), COPD status (diagnosed, at risk).
The robustness of our results of the primary outcome 
for smoking cessation was tested by conducting a best- and 
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a worst-case scenario, where respondents lost to follow-up 
were considered to have quit smoking in the best-case sce-
nario and considered to still be smoking in the worst-case 
scenario. In addition, as a sensitivity analysis, the intervention 
effect on the behavior-change score was tested using logistic 
regression analysis.
All statistical analyses were performed using IBM SPSS 
(v 19). Two-sided P values 0.05 were considered statisti-
cally significant.
Results
recruitment
A total of 7,179 individuals were invited for the study of 
which 3,035 declined to participate, 2,790 did not meet the 
inclusion criteria, and 29 were excluded because they did 
not complete the baseline questionnaire (n=24) or provided 
unreliable responses (n=5). Responses were unreliable if 
answers were straight lined (ie, the same answer options 
selected for each set of items) or the questionnaire was 
completed within 3 minutes (which was considered to be 
unrealistically fast).
A total of 1,325 participants (1,282 in the online group 
and 43 in the general practice group) completed the baseline 
questionnaire and were randomly assigned to the experi-
mental (online group: n=641, general practice group: n=21) 
or control group (online group: n=641, general practice 
group: n=22). Of the 1,325 participants, 1,071 (80.8%) 
completed the 6-month follow-up questionnaire, including 
1,048 (81.7%) of the online group and 23 (53.5%) of the 
general practice group. Eighteen participants of the online 
group were excluded from further analyses, due to a high 
level of suspicion of interference by someone other than the 
participant, (eg, a partner with whom they shared an email 
address). Participants were excluded when at least two of the 
following variables did not match their Flycatcher profile 
on the follow-up questionnaire: sex, day of birth, month of 
birth, year of birth. If only one variable was inconsistent or 
day and month were reversed, we suspected a typing error 
and did not exclude those participants.
In the group of smokers, 447 participants were included of 
whom 341 completed the follow-up questionnaire. Figure 1 
shows the CONSORT diagram of our RCT.
sample characteristics
Table 2 shows the baseline characteristics of the overall 
sample and the experimental and control groups separately. 
The only significant difference between the groups was the 
employment status of participants (P=0.039). As for the 
participants who smoked at baseline, we did not find any 
significant differences in baseline characteristics between 
the groups.
More participants were lost to follow-up in the general 
practice group (46.5%) than in the online group (18.5%) 
(P.001), more in the experimental group (22.8%) than in the 
control group (16%) (P=.002), more smokers (23.7%) than 
non-smokers (17.2%) (P=.005), and more female (22.6%) 
than male participants (15.9%) (P=.002). Participants lost 
to follow-up were also significantly younger (mean =55.9 
years) than completing participants (mean =58.1 years) 
(P0.001).
application use
The application was used by 237 (36%) participants of the 
experimental group (ie, at least one of the six components 
of a behavior-change module was completed). The average 
number of components completed by those participants 
was 2.1 (standard deviation =2.4, range 1–21). For physi-
cal activity, 193 (29.3%) of the participants completed at 
least one intervention component. For smoking cessation, 
51 (21.2%) of the smokers at baseline, and seven (1.7%) of 
the nonsmokers at baseline completed at least one interven-
tion component (although nonsmokers were not included in 
the effect analyses for smoking cessation). Table 3 shows 
how many participants completed zero, one, two, or three or 
more intervention components of both modules.
Intervention effect
Before correction for baseline characteristics, no significant 
treatment effect was found for any primary or secondary 
outcome, except clinical disease control. After correction, 
all effects were nonsignificant (Table 4).
As for sensitivity analyses, similar results were found 
for the primary outcomes. More specifically, per protocol 
analyses yielded nonsignificant results for both primary 
outcomes (Table 5). Regarding physical activity, all inter-
action terms were nonsignificant. Also, when evaluating for 
smoking cessation, neither the uncorrected nor corrected 
effects on 7-day point prevalence abstinence were significant 
for best- or worst-case scenarios. All subgroup analyses for 
both outcomes were nonsignificant. Besides, uncorrected and 
corrected analyses on the behavior-change score, combining 
the two behaviors, yielded nonsignificant results.
Discussion
This study examined the effects of a computer-tailored COPD 
self-management intervention. The intervention had no sig-
nificant impact on the primary outcome measures (physical 
activity and smoking), or on the secondary outcome measures 
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Table 2 Baseline characteristics of study participants – overall, experimental and control group
Characteristic Overall sample  
(n=1,307)
Experimental group  
(n=658)
Control group 
(n=649)
age, years (mean [sD]) 57.6 (7.2) 57.7 (7.3) 57.6 (7.2)
Male (n [%]) 627 (48.0) 326 (49.5) 301 (46.4)
education level (n [%])
Primary school/basic vocational school 386 (29.5) 191 (29.0) 195 (30.0)
secondary vocational school/high school degree 427 (32.7) 209 (31.8) 218 (33.6)
higher professional degree/university degree 494 (37.8) 258 (39.2) 236 (36.4)
Current employment status (n [%])
employed 670 (51.3) 356 (54.1) 314 (48.4)
not employed 637 (48.7) 302 (45.9) 335 (51.6)*
Marital status (n [%])
single/divorced/widowed 348 (26.6) 171 (26.0) 177 (27.3)
In a relationship/living together/married 959 (73.4) 487 (74.0) 472 (72.7)
COPD status (n [%])
Diagnosed with COPD 284 (21.7) 146 (22.2) 138 (21.3)
Increased risk for COPD per rhsQ19 1,023 (78.3) 512 (77.8) 511 (78.7)
Comorbidity (n [%])
1 chronic condition 604 (46.2) 292 (44.4) 312 (48.1)
respiratory disease 224 (17.1) 106 (16.1) 118 (18.2)
Cancer 53 (4.1) 30 (4.6) 23 (3.5)
Diabetes 120 (9.2) 57 (8.7) 63 (9.7)
Cardiovascular disease 200 (15.3) 98 (14.9) 102 (15.7)
Musculoskeletal disorder 90 (6.9) 41 (6.2) 49 (7.6)
Other chronic condition 124 (9.5) 58 (8.8) 66 (10.2)
MrC dyspnea36 (n=1,305)
no breathlessness 359 (27.5) 177 (26.9) 182 (28.1)
1 523 (40.1) 264 (40.2) 259 (40.0)
2 318 (24.4) 167 (25.4) 151 (23.3)
3 75 (5.7) 34 (5.2) 41 (6.3)
4 19 (1.5) 9 (1.4) 10 (1.5)
5 11 (0.8) 6 (0.9) 5 (0.8)
smoking status
Currently smoking 447 (34.2) 241 (36.6) 206 (31.7)
Currently not smoking 860 (65.8) 417 (63.4) 443 (68.3)
number of cigarettes smoked/day among smokers, n=447 (mean [sD]) 19.3 (12.1) 19.0 (12.3) 19.8 (11.9)
FTnD score (range 0–10)38 among smokers, n=447 (mean [sD]) 4.2 (2.3) 4.1 (2.3) 4.4 (2.3)
number of previous quit attempts among smokers, n=447 (mean [sD]) 3.8 (8.8) 3.1 (4.0) 4.8 (12.2)
Intention to quit smoking (range 1–7) among smokers, n=447 (mean [sD]) 3.7 (1.9) 3.7 (2.0) 3.7 (1.9)
level of physical activity (MeT per week), n=1,096 (mean [sD]) 4,012.6 (3,933.3) 4,108.7 (4,034.0) 3,914.1 (3,828.4)
Intention to be more physically active (range 1–7) (mean [sD]) 3.2 (1.7) 3.2 (1.7) 3.1 (1.7)
CCQ score (range 0–6)37 (mean [sD]) 1.0 (0.9) 1.0 (0.9) 1.0 (0.8)
Note: *P0.05.
Abbreviations: CCQ, Clinical COPD Questionnaire; FTnD, Fagerström Test for nicotine Dependence; MeT, metabolic equivalent task; MrC, Medical research Council; 
rhsQ, respiratory health screening Questionnaire; sD, standard deviation.
(intention to change behavior and dyspnea). The only sig-
nificant effect found was on clinical disease control, but the 
improvement was too small to have clinical relevance42 and 
was not significant after correction for relevant baseline char-
acteristics. Moreover, a borderline significant effect for smok-
ing was found when analyzing the effects among those who 
completed at least two intervention components. Also, the 
effect size, for both smoking and physical activity, increased 
as more intervention components were used. Yet, possibly 
due to the sample size and thus decreased power of the study, 
these analyses did not yield a significant effect.
Possible explanations for the lack of effect may be: 
(a) low exposure to the intervention, (b) that the interven-
tion method was not sufficient for our target population, and 
(c) inadequate content of the intervention itself. Although it 
was not significant, the trend was for an increased effect size 
as the participants completed more of the six intervention 
components. This helps verify the importance of exposure 
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to the application and correlates with other studies which 
have shown that this is essential for the effectiveness of 
such interventions.43,44 To enhance exposure to the inter-
vention, we used different strategies to attract participants 
to the application: sending email prompts every 2 weeks, 
of which some referred to new content on the website, as 
this has been shown to effectively increase application 
use;28 including multiple feedback moments to evaluate 
participants’ behavior and track their goal achievement;45,46 
prompting revisits to the application and evaluate these 
previously set goals; and embedding a website that provided 
regular news updates,45–47 such as behavioral journalism 
stories,48 which were personal stories addressing how other 
patients overcame potential barriers to use the application 
and improve their health behavior. Additionally, since the 
length of the program was of concern in the pilot study,17 we 
separated the two modules (smoking cessation and physical 
activity) into six small components, giving participants the 
opportunity to decide which components they wanted to 
complete, and consequently, how much time they wanted 
to spend working with the application. Unfortunately, only 
one out of three participants completed one or more of the 
six intervention components. In hindsight, giving participants 
an option to choose intervention components based on the 
results of our pilot study was probably not desirable, since 
it has recently been shown that less freedom of navigation 
on a website enhances application use.49,50 The intervention 
did not include ongoing peer or counselor support (eg, by a 
practice nurse) which could have improved the exposure to 
the application.47
Another potential cause for our study results could 
be that the intervention method was not sufficient for our 
target population. Although similar computer-tailoring 
approaches have found significant effects among the general 
population,11,14,25,26 several other studies reported a relatively 
low success rate of disease-management programs for COPD 
patients51–53 and found that COPD patients are more likely to 
have characteristics that are associated with a higher resis-
tance to smoking cessation interventions54 than other target 
populations. Negative results are not uncommon in COPD 
self-management studies according to a systematic review by 
Jonsdottir.5 The author describes the need for a paradigm shift 
in which a prominent health professional-centered approach 
should make way for a patient-family-centered approach with 
Table 3 number of participants (%) who completed intervention 
components of the physical activity and smoking cessation modules
Module Number of components completed
0 1 2 3
Physical activity 465 (70.7) 107 (16.3) 48 (7.3) 38 (5.8)
smoking cessation,  
among smokers
190 (78.8) 29 (12.0) 12 (5.0) 10 (4.1)
Table 4 effects of the web-based COPD self-management intervention on all primary and secondary outcomes
Primary and secondary outcomes Uncorrected effects Corrected effects
7-day point prevalence abstinencea Or=1.12, (0.45; 2.77*), P=0.810 Or=1.06, (0.43; 2.66), P=0.895
MeT minutes a weekb b=-64.70, (-455.39; 326.00), P=0.745 b=-84.33, (-476.39; 307.74), P=0.673
24-hour point prevalence abstinencea Or=0.77, (0.36; 1.67), P=0.510 Or=0.72, (0.33; 1.59), P=0.420
Prolonged abstinencea Or=0.90, (0.35; 2.34), P=0.834 Or=0.86, (0.33; 2.25), P=0.766
Continued abstinencea Or=1.02, (0.39; 2.72), P=0.963 Or=0.98, (0.37; 2.63), P=0.969
number of cigarettesc b=-0.08, (-1.82; 1.65), P=0.925 b=0.11, (-1.61; 1.84), P=0.899
Intention to quit smokingd b=-0.01, (-0.31; 0.28), P=0.937 b=-0.03, (-0.32; 0.26), P=0.826
number of quit attemptse b=-0.36, (-1.10; 0.37), P=0.334 b=-0.38, (-1.11; 0.36), P=0.312
Intention to increase physical activityf b=0.00, (-0.17; 0.17), P=0.991 b=0.00, (-0.17; 0.17), P=0.987
Clinical disease controlg b=-0.06, (-0.11; -0.01), P=0.010 b=-0.03, (-0.07; 0.01), P=0.134
Dyspnea statush Or=1.16, (0.89; 1.51), P=0.283 Or=1.28, (0.92; 1.79), P=0.149
Notes: *95% confidence intervals are shown within brackets. alogistic regression analyses were performed. The corrected analysis only included intention to quit smoking, 
as including more variables would have overloaded the model. The number of smokers in the general practice group followed up was too small (n=4) to yield reliable results 
when including recruitment channel in the model. blinear mixed-model analyses were performed, corrected for age, sex, recruitment channel, smoking status, employment 
status, comorbidity (yes/no), MrC score, and intention to increase physical activity. clinear mixed-model analyses were performed, corrected for age, sex, marital status, 
CCQ score, level of education, MrC score, and FTnD score. dlinear mixed-model analyses were performed, corrected for age, sex, level of education, CCQ score, MrC 
score, number of quit attempts, and employment status. elinear regression analyses were performed, corrected for age, sex, level of education, CCQ score, MrC score, and 
FTnD score. flinear mixed-model analyses were performed, corrected for age, sex, recruitment channel, smoking status, employment status, and MrC score. glinear mixed-
model analyses were performed, corrected for age, sex, recruitment channel, smoking status, employment status, COPD status, comorbidity (yes/no), marital status, level of 
physical activity, MrC score, and level of education. hlogistic regression analyses were performed, corrected for age, sex, recruitment channel, smoking status, employment 
status, COPD status, comorbidity (yes/no), marital status, level of physical activity, CCQ score, and level of education. Dyspnea status was recoded (0= participants who 
experienced a form of breathlessness and scored 1–5 on the MrC dyspnea score; 1= participants who indicated to have no breathlessness).
Abbreviations: b, estimated mean difference; CCQ, Clinical COPD Questionnaire; FTnD, Fagerström Test for nicotine Dependence; MeT, metabolic equivalent task; 
MrC, Medical research Council; Or, odds ratio.
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Table 5 Corrected effects of the per protocol analyses for primary outcomes
Primary outcomes At least 1 component completed At least 2 components completed At least 3 components completed
7-day point prevalence  
abstinencea
Or=1.75, (0.51; 6.00), P=0.371 Or=3.57, (0.87; 14.73), P=0.078 no reliable resultsc 
MeT minutes a weekb b=-101.58, (-653.10; 449.94), P=0.718 b=120.92, (-683.86; 925.71), P=0.768 b=813.44, (-383.29; 2,010.17), P=0.182
Notes: 95% confidence interval between brackets. alogistic regression analyses were performed. This analysis did not include covariates due to the small number of events 
(successful behavior changes). blinear mixed-model analyses were performed, corrected for age, sex, recruitment channel, smoking status, employment status, comorbidity 
(yes/no), MrC score, intention to increase physical activity; cno events (successful behavior change) in the experimental group.
Abbreviations: b, estimated mean difference; MeT, metabolic equivalent task; Or, odds ratio.
emphasis on the relationship with the health care professional. 
As we were aware of this, the MasterYourBreath intervention 
was patient-centered, and social influence of family members 
was addressed in the intervention. However, the application 
did not enable the active participation of family members. 
An improvement to future versions could be to integrate 
the MasterYourBreath intervention with a social media 
platform to facilitate engagement of the family members 
in the patient’s self-management process. The relationship 
with the health care professional was indeed emphasized in 
the original version of the MasterYourBreath intervention, 
by integration of the application in primary care, but recruit-
ing the number of participants necessary for an RCT from 
primary care practices was found to be unfeasible in the pilot 
study,17 so the original study design was changed.
Another possible cause for the lack of effect could be 
related to the web-based intervention content itself. We used 
key behavioral determinants that were experimentally tested 
in the Dutch population but not validated for COPD patients. 
The usability study in which we adjusted these determinants 
for COPD patients16 is not a replacement for a validation 
study. Behavioral determinants for this specific group might 
be different from the general Dutch population. For example, 
COPD patients are likely to experience different barriers to 
physical activity due to disease complications. Moreover, 
the main difference we found comparing our application 
to programs that were very similar but found positive 
intervention effects11,14,25,26,43,55 was that participants in our 
study were free to choose which intervention components 
they wanted to complete. These other programs contained 
similar tailored messages, but directed participants through 
a specified intervention pathway. As described previously, 
this strategy might increase exposure, as it limits freedom 
of navigation. Instead of shortening the intervention content 
by tailoring the use of components to user’s preference,10 
it may have been more effective to offer participants only 
components adapted to their level of motivation to change 
their behavior; Stanczyk et al55 found this strategy effective. 
Peels et al56 tested a web-based basic version of their program 
and a version in which they added additional environmental 
information with links to other resources to increase physi-
cal activity in adults aged 50 and over. They found that only 
the latter was not effective. The authors suspected that par-
ticipants might have been distracted from the intervention 
pathway by visiting other resources. Likewise, the provision 
of additional information and self-management resources in 
the MasterYourBreath application, including home exercises 
and links to other websites might have decreased a potential 
intervention effect, as these could have distracted participants 
from the intervention components, which was the core con-
tent of the intervention.
Limitations
Our study had several limitations. First, despite our relatively 
large sample of participants, compared to many other COPD 
self-management studies,5 our study still lacked power con-
cerning the primary outcome for smoking cessation. The 
number of smokers at the start of the study was lower than 
expected, and loss to follow-up among smokers was higher 
than among nonsmokers.
Second, we were not able to evaluate selection bias, 
because we could not collect additional data to differentiate 
between participants who enrolled versus those who declined 
participation. The clinical information that would help us 
address selection bias was not available from the online 
recruiting company.
Third, the inclusion of people at risk for COPD may make 
it more difficult to compare our results with self-management 
studies that include only COPD patients. However, we argue 
that including individuals at risk for COPD is clinically rel-
evant, since early smoking cessation is pivotally important 
for a greater health benefit in COPD.57 Including both diag-
nosed patients and individuals at risk for COPD also poses 
a methodological challenge, since these groups may benefit 
from different interventions. However, the approach to care 
in the MasterYourBreath program has been tailored to vary-
ing levels of COPD (risk), and thus it was able to address 
differing patient needs.
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Fourth, while our intentions were to do so, we were not 
able to integrate the MasterYourBreath intervention into 
the Dutch COPD disease-management approach,18 due to 
recruitment issues.17 We know that it is important that COPD 
self-management interventions can be incorporated in an 
existing health care structure.58–60 The recruitment strategy 
used in this RCT (including an online group and individuals 
at risk for COPD) was certainly beneficial for the sample size 
of our RCT, but hampered the integration of our intervention 
in primary care.
Conclusion
MasterYourBreath, a web-based COPD self-management 
intervention with tailored feedback, did not show statistically 
significant effects on health-related behavioral or clinical 
outcomes. Given the structurally low exposure to the appli-
cation in this study, we believe more research is needed to 
find effective strategies to increase the use of the web-based 
applications by COPD patients. To further explain this phe-
nomenon and to generate hypotheses for better strategies, we 
will reevaluate our RCT and explore in depth the character-
istics of the intervention and the participants that may have 
contributed to the use and appreciation of the application.
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